David Macklin

1.5K posts

David Macklin banner
David Macklin

David Macklin

@DavidMacklinMD

MD focused 24/7 on Wt. mngmnt since 2004. Director Medcan Wt. Mngmnt, Director Mt Sinai Hospital High Risk Pregnancy Wt. Mngmnt. Lecturer University of Toronto

Toronto Katılım Mart 2010
775 Takip Edilen1.8K Takipçiler
Sabitlenmiş Tweet
David Macklin
David Macklin@DavidMacklinMD·
Me: At conference eating a sandwich. Keto guru Doc: “You know that bread will kill you”. Me: “My grandfather lived to 104 years old”. Keto guru Doc: “By eating bread”? Me: “No, by minding his own business”.
Toronto, Ontario 🇨🇦 English
15
75
961
0
David Macklin
David Macklin@DavidMacklinMD·
The GLP-1 receptor agonist semaglutide (Ozempic®/Wegovy®) -soon to be available at 7.2 mg once weekly- has been shown to reduce the incidence of cardiovascular death, non-fatal heart attacks, and non-fatal strokes in people living with established heart disease and overweight or obesity. So… cardiologists will now be prescribing GLP-1 agonists to their patients more frequently. If you are someone prescribing a GLP-1 receptor agonist or personally starting one, you’ll find this podcast extremely relevant. I was recently invited by @Dr. Grace Chua and the @Canadian Cardiovascular Society to discuss exactly this on the Cardio Connector Podcast episode “Sustaining Success: Real-World Approaches to Obesity Management.” In the episode, I share three key principles every cardiologist should integrate when prescribing these medications: 1️⃣ Addressing internalized weight bias
2️⃣ Discussing appetite dysregulation
3️⃣ Setting realistic weight loss expectations Integrating these principles is: 
🔹 Straightforward
✅ Simple
⏱️ Not time-consuming
⚡ Yet critical I suggest that doing so will meaningfully improve: 
✅ Medication adherence
❤️ Clinical outcomes 🎧 Listen to the full episode here: ccs.simplecast.com/episodes/susta… What challenges or successes are you seeing when discussing GLP-1 therapies with your patients (or in your own experience)? I’d love to hear your thoughts in the comments 👇 #Cardiology #GLP1 #Semaglutide #Ozempic #Wegovy #ObesityMedicine #PatientAdherence #CanadianCardiovascularSociety #HeartHealth
English
0
0
2
181
Shaun Maguire
Shaun Maguire@shaunmmaguire·
The UAE is a rare country that combines vision with courage The world sees the skyscrapers they have built But most don't know about the work they have done to root out extremism This is an incredible country with remarkable leadership The UAE will thrive this century
🇦🇪 HGS@Sajwani

Never bet against Dubai 💙🇦🇪

English
53
179
1.4K
85.1K
Crémieux
Crémieux@cremieuxrecueil·
Some patients are too lazy to wait 30 minutes to take Novo's pill to lose weight. When Eli Lilly drops orforglipron–which is more effective, requires no wait, and is supposedly being launched at a lower price–they're just going to nab up the entire market.
Crémieux tweet media
Alex Kesin@alexkesin

And so begins the Wegovy pill reality check.... Did $NVO really think 30 minutes fasting on 4 oz of water was some trivial ask patients would just be fine with?!

English
35
5
287
41.9K
Pierre Poilievre
Pierre Poilievre@PierrePoilievre·
Congratulations to President Trump on successfully arresting narco-terrorist and socialist dictator Nicolas Maduro, who should live out his days in prison. The legitimate winner of the most recent Venezuelan elections, Edmundo González, should take office along with the courageous hero and voice of the Venezuelan people, María Corina Machado. Down with socialism. Long live freedom.
English
7.5K
8.7K
63.8K
4.5M
David Macklin
David Macklin@DavidMacklinMD·
@shaunmmaguire @sethbannon @msuster @grok Obesity medicine expert here. FYI fMRI is validated and provides our best in human mechanistic data showing how people with obesity have hyper responsivity to food stimuli (photos) in the “human motivation to food system”.
English
0
0
0
224
David Macklin
David Macklin@DavidMacklinMD·
@drmarkhyman Mark, can you explain the difference between absolute risk and relative risk?
English
0
0
0
28
Mark Hyman, M.D.
Mark Hyman, M.D.@drmarkhyman·
Alcohol can increase your risk of dementia. A brand new study out of Oxford followed 559,559 adults for up to 12 years and found shocking results on alcohol and dementia: - Heavy drinkers: 41% higher dementia risk - Alcohol use disorder: 51% higher risk - Genetic analysis: 15% dementia increase per standard deviation of weekly drinks - with NO protective effect
English
16
41
213
22.6K
David Macklin
David Macklin@DavidMacklinMD·
@drmarkhyman Insulin resistance does not cause obesity. Obesity causes insulin resistance . Over eating does not cause obesity. Obesity causes over eating.
English
0
0
2
225
Mark Hyman, M.D.
Mark Hyman, M.D.@drmarkhyman·
Insulin resistance affects 88% of Americans but only 12% know they have it. It's the root cause of obesity, diabetes, heart disease, and Alzheimer's. Yet most doctors never test for it until you're already sick.
English
49
68
464
27.6K
Stephan J. Guyenet
Stephan J. Guyenet@sguyenet·
@cremieuxrecueil I don't think it's accurate to say people "keep it off". As you noted in your post, trials suggest that most weight is regained when the drugs are stopped. It is good news that apparently, not *all* of the weight is regained.
English
1
0
2
166
Crémieux
Crémieux@cremieuxrecueil·
One of the major concerns about GLP-1RAs like Ozempic is that people will regain lots of weight. Late last year, reassuring data came out showing that people generally didn't regain the weight at one year. Now we have two years of data and most people keep the weight off!
Crémieux tweet media
English
41
94
1.5K
95.8K
Kevin Hall
Kevin Hall@KevinH_PhD·
People often ask me if my studies are still running at NIH after I felt compelled to retire earlier this year. The answer is yes, and @AaronHengist is still recruiting for this one testing the effects on sleeping energy expenditure of nicotinamide riboside supplementation during a ketogenic diet.
NIH Clinical Center@NIHClinicalCntr

Interested in keto diets and sleep patterns? Scientists at NIDDK want to know if an investigational dietary supplement impacts calorie burn during sleep. Call the NIH Office of Patient Recruitment at 866-444-1134. Refer to study #001690-DK. go.nih.gov/w4TAEXE

English
1
5
30
5.7K
David Macklin
David Macklin@DavidMacklinMD·
@MichaelAlbertMD @GLP1Insider Hey Michael, I am at ECO in Malaga Spain this week. I’m sure this will be a hot subject, I’ll be sure to mention your data.😀Congratulations, yours is a model obesity clinic👍
English
1
0
1
111
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
📊 NEW STUDY: Real-World Semaglutide: great promise, stubborn barriers - - - Key data (N = 1,072): 🔹 18.6% never started treatment (due to access/cost issues) 🔹 25% stopped within a year (side effects, other factors) 🔹 56.4% 1-year adherence overall 🔹 8.8% mean total weight-loss (%TWL) across all who were prescribed 🔹 10.9% mean %TWL among those who stayed on therapy a full year 🔹 13.6% vs 10.1 %: greater loss after Roux-en-Y gastric bypass (RYGB) than in surgery-naïve patients (P = 0.022) ↪️ Lower response when BMI > 40 💡 STEP Program reported ≈ 14-16% weight-loss at one year with semaglutide 2.4 mg + lifestyle support — nearly double today’s real-world figure. By comparison, @accomplishHLTH has presented three Real-World Cohorts, all of which achieved mean TBWL > 20% at one year (with observational limitations) with integrative, multi-disciplinary specialty obesity care. @accomplishHLTH is presenting its 4th cohort, which includes combined bariatric and medical therapy, at the @ASMBS Annual Meeting in June 2025. H/t @Nimeri_MD for the slides. - - - Study: journals.lww.com/annalsofsurger…
Michael Albert, MD tweet mediaMichael Albert, MD tweet media
English
1
7
34
3K
David Macklin
David Macklin@DavidMacklinMD·
@sguyenet @HermanPontzer Hey @sguyenet and @HermanPontzer, happy new year. Quick switch to the other side of the energy equation. High levels of exercise leading to lower calorie intake as a consequence of ⬇️ incentive motivation and ⬆️ executive self regulation? Lots of evidence there…
English
1
0
2
140
Stephan J. Guyenet
Stephan J. Guyenet@sguyenet·
@HermanPontzer Interesting thought. It would be pretty surprising if exercise caused weight loss but there was no relationship to dose though, right?
English
2
0
1
446
Herman Pontzer
Herman Pontzer@HermanPontzer·
Meta-analysis of exercise RCTs making the rounds today shows what we’ve known: expect ~2kg wt loss from exercise, some get more, many get 0. Text from Burn, fig from paper. jamanetwork.com/journals/jaman…
Herman Pontzer tweet mediaHerman Pontzer tweet media
English
3
11
62
8.3K
David Macklin
David Macklin@DavidMacklinMD·
@Tellit007 @MichaelMindrum Thinking this through… Why are obesity rates in Kuwait, Qatar, and Egypt equal to or higher than the U.S., despite significantly lower consumption of ultra-processed foods and less sedentary lifestyles?
David Macklin tweet media
English
0
0
1
49
David Macklin
David Macklin@DavidMacklinMD·
@Tellit007 @MichaelMindrum Countries with obesity rates within 2–3% of the US often lack the same obesogenic ultra-processed food environment. What else might be driving the numbers?
David Macklin tweet media
English
2
0
0
79
David Macklin
David Macklin@DavidMacklinMD·
@MichaelMindrum Oh and there is no way that obesity prevalence in Canada is only 26%. Certainly above 30%.
English
0
0
1
54
David Macklin
David Macklin@DavidMacklinMD·
@MichaelMindrum People would be tempted to say the signal is the US food environment, but the answer is likely genetics… look at the comparators. For example, US rates are similar to Kuwait. US is a melting pot of obesity associated genes.
English
4
0
1
171
Michael Weintraub, MD
Michael Weintraub, MD@MWeintraubMD·
Obesity stands as one of the primary preventable causes of death, surpassed only by smoking. Confronting obesity has escalated into a public health crisis that can no longer be overlooked.
English
1
1
8
677